Adapting to Immuno-Oncology’s R&D Challenges: Refocusing on Innate Immunity as a “Next Big Thing” in Cancer Immunotherapy
Adapting to Immuno-Oncology’s R&D Challenges: Refocusing on Innate Immunity as a “Next Big Thing” in Cancer Immunotherapy
This session brings together a diverse array of biotech with a range of platforms and modalities to modulate innate pathways towards the goal of enhancing the ability of the patient’s immune system, with or even without checkpoint inhibitors, to control cancer.
On-Demand Webinar
Oct 24, 2024
